MRI spectroscopy, often called MRS, is used to measure the chemical composition of living tissue without surgery or needles. While a standard MRI creates detailed images of your body’s structures, MRS goes a step further by identifying specific chemicals (metabolites) inside those structures. This makes it especially valuable for diagnosing brain tumors, detecting metabolic diseases in children, localizing seizure origins in epilepsy, and investigating prostate cancer.
How MRS Differs From a Standard MRI
A conventional MRI scan produces pictures of organs and tissues based on water content. MRS uses the same machine but reads the chemical fingerprints of molecules inside a targeted area. The result is a graph, not an image, showing peaks that correspond to different metabolites. Each chemical has a characteristic peak location, so radiologists can measure how much of each substance is present and compare those levels to what’s expected in healthy tissue.
The technique works best at higher magnetic field strengths. Scanners operating at 3 Tesla (3T) produce signals 49 to 73% stronger than 1.5T machines for key brain chemicals, with slightly better ability to distinguish one metabolite peak from another. Most clinical MRS today is performed at 3T, though 1.5T systems can still provide useful results for many applications.
Grading Brain Tumors
One of the most established uses of MRS is evaluating brain tumors, particularly gliomas. A standard MRI can show where a tumor is and how large it is, but MRS helps determine how aggressive it might be. It does this by measuring the balance between chemicals that reflect cell turnover, energy metabolism, and nerve cell health.
In brain tissue, three metabolites matter most. Choline rises when cells are rapidly dividing. N-acetylaspartate (NAA) is a marker of healthy, functioning neurons, so it drops when tumor cells replace normal brain tissue. Creatine reflects energy metabolism and serves as an internal reference point. High-grade gliomas show significantly elevated choline-to-creatine ratios compared to low-grade tumors. They also show spikes in lipid and lactate signals, which indicate tissue breakdown and oxygen-starved metabolism, hallmarks of aggressive cancer. In one large study, a choline-to-creatine ratio above roughly 1.5 was the cutoff separating low-grade from high-grade tumors.
MRS is also useful after treatment. When a brain tumor has been treated with radiation, follow-up MRI scans sometimes show a growing bright spot that could be the tumor coming back or could simply be radiation-induced tissue damage. MRS can help distinguish between the two because recurrent tumor tissue has a different chemical profile than inflamed but non-cancerous tissue.
Localizing Seizure Origins in Epilepsy
For people with epilepsy that doesn’t respond to medication, surgery to remove the seizure-generating area of the brain can be life-changing, but only if surgeons know exactly where seizures start. MRS contributes to that localization process. In patients with temporal lobe epilepsy, the most common surgical form, NAA levels are typically reduced in the affected hippocampus, reflecting chronic nerve cell loss and scarring.
Timing matters too. When MRS is performed shortly after a seizure, it can detect a temporary spike in lactate, a byproduct of intense, oxygen-depleted brain activity, concentrated in the region where the seizure originated. In focal seizures, this lactate increase is higher on the side of the brain generating the seizure. During generalized seizures, the lactate rise becomes more widespread and loses that one-sided pattern. This postictal window offers an additional clue for surgical planning.
Detecting Metabolic Diseases in Children
MRS plays a particularly powerful role in pediatric neurology, where inherited metabolic disorders can be difficult to diagnose quickly. Many of these conditions produce distinctive chemical signatures that MRS can pick up in the brain, sometimes before genetic test results are available.
Canavan disease, a rare condition that destroys the white matter of the brain, produces what neurologists consider a textbook MRS finding: an abnormally high NAA peak. This is one of the few situations where elevated NAA signals disease rather than health, because the condition prevents the brain from properly breaking down this chemical.
Other metabolic conditions have their own fingerprints:
- Creatine deficiency disorders show creatine peaks reduced to less than 10% of normal, which is considered confirmatory for the diagnosis.
- Maple syrup urine disease produces a characteristic broadened peak from accumulated branched-chain amino acids that flips direction when the scan settings are adjusted, a behavior unique to this condition.
- Mitochondrial diseases show elevated lactate, reflecting impaired energy production, though this finding alone isn’t specific enough to confirm the diagnosis.
- Urea cycle disorders during episodes of high ammonia levels show increased glutamine and lactate alongside decreased choline.
- Glycine encephalopathy reveals a glycine peak that is best detected with specific scan settings, since at other settings it overlaps with a normal brain chemical.
For pediatric neurologists, MRS can narrow down a long list of possible diagnoses and guide which genetic tests to prioritize, saving critical time in conditions where early treatment changes outcomes.
Early Clues in Alzheimer’s Disease
In Alzheimer’s disease, MRS detects two consistent changes: decreased NAA (reflecting nerve cell damage) and increased myo-inositol (a marker of glial cell activity and inflammation). What makes this particularly interesting is the timing. Research published in Neurology found that myo-inositol levels rise in cognitively healthy people who carry early signs of Alzheimer’s pathology, specifically those who already have amyloid protein accumulating in the brain but haven’t yet developed memory problems.
People who carry the APOE ε4 gene variant, the strongest genetic risk factor for Alzheimer’s, show significantly higher myo-inositol levels even before amyloid buildup becomes detectable in spinal fluid tests. This suggests MRS could eventually help identify people at risk for Alzheimer’s before the disease takes hold, though it is not currently used as a standalone screening tool.
Prostate Cancer Assessment
MRS is not limited to the brain. In prostate cancer evaluation, it measures the balance between citrate and choline in prostate tissue. Healthy prostate cells produce and store high levels of citrate. When those cells become cancerous, citrate drops sharply while choline rises, reflecting the rapid cell membrane turnover of malignant tissue.
Radiologists calculate the ratio of choline plus creatine to citrate. A ratio of 1.1 or higher flags a voxel (a small cube of tissue on the scan) as suspicious for cancer. Combined with standard MRI, this chemical information improves the accuracy of detecting and localizing tumors within the prostate, which is particularly helpful for guiding biopsy needles toward the most suspicious areas rather than sampling blindly.
Depression and Psychiatric Research
MRS has become an important research tool in psychiatry, even though it hasn’t yet translated into routine clinical diagnosis. In major depressive disorder, MRS studies consistently show reduced levels of both glutamate (the brain’s primary excitatory chemical messenger) and GABA (the primary inhibitory one) across several brain regions, including the prefrontal cortex and anterior cingulate cortex.
Unmedicated patients with depression show lower levels of both chemicals compared to those on treatment, and people with treatment-resistant depression have even lower GABA levels than those who respond to medication. One study from Yale found roughly a 25% reduction in energy production within excitatory neurons in the visual cortex of depressed subjects. Animal models of depression mirror these findings, showing 40% reductions in excitatory nerve cell metabolism and 20% reductions in inhibitory nerve cell metabolism in the prefrontal cortex.
These findings are reshaping how researchers understand depression, shifting focus from simple chemical imbalances to broader disruptions in how the brain produces and uses energy at the cellular level.
What the Scan Is Like
From your perspective, an MRS scan feels identical to a regular MRI. You lie inside the same machine, hear the same loud knocking sounds, and stay still for the same general duration. The MRS portion typically adds 10 to 15 minutes to a standard MRI session. No contrast dye or injection is needed for the spectroscopy component, though contrast may still be used for the imaging portion of the exam. The radiologist selects specific regions of interest on the MRI images, and the scanner collects the chemical data from those targeted areas.
Results are interpreted alongside the standard MRI images, giving your medical team both structural and biochemical information from a single scanning session.